Home/Filings/4/0001415889-22-000046
4//SEC Filing

Smith Mark Alan 4

Accession 0001415889-22-000046

CIK 0001411685other

Filed

Jan 2, 7:00 PM ET

Accepted

Jan 3, 4:25 PM ET

Size

4.8 KB

Accession

0001415889-22-000046

Insider Transaction Report

Form 4
Period: 2021-12-31
Smith Mark Alan
CHIEF MEDICAL OFFICER
Transactions
  • Award

    Common Stock

    2021-12-31$1.66/sh+2,655$4,40114,915 total
Footnotes (1)
  • [F1]Shares purchased under the VistaGen Therapeutics, Inc. 2019 Employee Stock Purchase Plan in a transaction exempt under Rule 16b-3(c)

Issuer

VistaGen Therapeutics, Inc.

CIK 0001411685

Entity typeother

Related Parties

1
  • filerCIK 0001677452

Filing Metadata

Form type
4
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:25 PM ET
Size
4.8 KB